Revolution Medicines, Inc 10-K for FY2024
Revolution Medicines, Inc. (RVMD)
10-K
2025-02-26
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
Revolution Medicines, Inc filed this 10-K on February 26, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $11.58M a year earlier
- Net loss
- $600.09M
- compared with a net loss of $436.37M a year earlier
- Diluted EPS
- -$3.58
- compared with -$3.86 a year earlier